BioSpace News Archive

The trial enrolled 31 patients in Italy, Greece and Israel, of which 28 patients were evaluable. While the primary endpoint of this study was overall safety, secondary endpoints were also evaluated.

Pharmaceutical manufacturing operations call for new technologies to solve challenges in the harvest, clarification, and purification processes of mAbs production, finds Frost & Sullivan

Envista is offering 26,768,000 shares of its common stock in the IPO.

Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced that Greenbrook TMS, a NeuroStar Advanced Therapy provider with 82 treatment centers across the U.S., has installed its 100th NeuroStar system.

Endo’s operating company Par Pharmaceutical, Inc. expects to distribute the product through specialty pharmacies beginning this month.

Accuray Incorporated (NASDAQ: ARAY) announced today that the Company will host an Investor Meeting during the American Society of Radiation Oncology (ASTRO) Annual Meeting, being held in Chicago, IL.

Industry veteran brings extensive experience driving the commercialization of robotic technologies within healthcare

Acquisition of Ophthalmic Instruments Distributor Further Strengthens Advancing Eyecare’s West Coast Presence

This Fall Eon has made it their mission to travel the USA and provide a complete data debt analysis of all historical patient data submitted to CMS to any qualified hospital with an active lung cancer screening program.

Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) (Prometic), a biopharmaceutical company focused on developing novel therapeutics to treat unmet needs in patients with liver, respiratory and kidney disease, today announced that members of the management team will provide a business overview and update at the H.C. Wainwright & Co. 21st Annual Global Investment Conference at 11:15 EDT on Tuesday, September 10, 2019 in New York, USA.